Reproduction studies in laboratory animals have not indicated any risks to the foetus but no controlled studies have so far been conducted in pregnant women. Therefore, this medication should only be used during pregnancy strictly as directed, with careful dosing under medical supervision.
Since the possibility of pyridostigmine diffusing into breast milk cannot be ruled out, nursing mothers are advised to refrain from breast feeding their babies during treatment.